ImageneBio, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
ImageneBio, Inc. (IMA) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2023-03-14
- ImageneBio, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $0.00.
- ImageneBio, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2021 was $0.00.
- ImageneBio, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2020 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-14 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-17 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |